Unlocking AI’s Potential for Precision Medicine: The Need for Causality

Randomized clinical trials (RCTs) have long been the gold standard for establishing causal relationships in medicine, ensuring that treatments are evaluated with minimal bias. However, despite their rigor, RCTs face limitations in uncovering personalized treatment effects.  Artificial intelligence (AI) presents an exciting opportunity to enhance RCTs, offering advanced data-driven insights and the ability to identify complex patterns in patient responses. However, AI’s integration into healthcare has been hindered by its reliance on correlation rather than causation, limiting its ability to guide clinical decision-making effectively. Causal learning offers a promising path forward, bridging the gap between AI’s predictive power and the causal rigor of RCTs. By incorporating causal inference techniques, AI can move beyond surface-level associations to uncover meaningful, actionable insights that drive personalized medicine. To illustrate this approach, we explore an RCT on continuous positive airway pressure (CPAP) treatment in patients with obstructive sleep apnea (OSA). A causal learning framework applied to this trial could refine our understanding of treatment effects across patient subgroups, leading to more precise recommendations and improved health outcomes.